197 related articles for article (PubMed ID: 31386030)
1. Time to focus on brain tumor-related epilepsy trials.
Gallagher P; Leach JP; Grant R
Neurooncol Pract; 2014 Sep; 1(3):123-133. PubMed ID: 31386030
[TBL] [Abstract][Full Text] [Related]
2. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
3. Management of epilepsy in brain tumor patients.
van der Meer PB; Taphoorn MJB; Koekkoek JAF
Curr Opin Oncol; 2022 Nov; 34(6):685-690. PubMed ID: 35838207
[TBL] [Abstract][Full Text] [Related]
4. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
Strozzi I; Nolan SJ; Sperling MR; Wingerchuk DM; Sirven J
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD001902. PubMed ID: 25922863
[TBL] [Abstract][Full Text] [Related]
5. Cognitive consequences of early versus late antiepileptic drug withdrawal after pediatric epilepsy surgery, the TimeToStop (TTS) trial: study protocol for a randomized controlled trial.
Boshuisen K; Lamberink HJ; van Schooneveld MM; Cross JH; Arzimanoglou A; van der Tweel I; Geleijns K; Uiterwaal CS; Braun KP
Trials; 2015 Oct; 16():482. PubMed ID: 26503021
[TBL] [Abstract][Full Text] [Related]
6. Prescription preferences of antiepileptic drugs in brain tumor patients: An international survey among EANO members.
van der Meer PB; Dirven L; van den Bent MJ; Preusser M; Taphoorn MJB; Rudá R; Koekkoek JAF
Neurooncol Pract; 2022 Apr; 9(2):105-113. PubMed ID: 35371521
[TBL] [Abstract][Full Text] [Related]
7. The withdrawal of antiepileptic drugs in patients with low-grade and anaplastic glioma.
Koekkoek JA; Dirven L; Taphoorn MJ
Expert Rev Neurother; 2017 Feb; 17(2):193-202. PubMed ID: 27484737
[TBL] [Abstract][Full Text] [Related]
8. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
Sirven JI; Sperling M; Wingerchuk DM
Cochrane Database Syst Rev; 2001; (3):CD001902. PubMed ID: 11687000
[TBL] [Abstract][Full Text] [Related]
9. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
10. Management of brain tumour related epilepsy (BTRE): a narrative review and therapy recommendations.
Vacher E; Rodriguez Ruiz M; Rees JH
Br J Neurosurg; 2023 Jan; ():1-8. PubMed ID: 36694327
[TBL] [Abstract][Full Text] [Related]
11. NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy.
Villanueva V; Saiz-Diaz R; Toledo M; Piera A; Mauri JA; Rodriguez-Uranga JJ; López-González FJ; Gómez-Ibáñez A; Garcés M; González de la Aleja J; Rodríguez-Osorio X; Palao-Duarte S; Castillo A; Bonet M; Ruiz-Giménez J; Palau J; Arcediano A; Toledo M; Gago A
Epilepsy Behav; 2016 Dec; 65():25-32. PubMed ID: 27863278
[TBL] [Abstract][Full Text] [Related]
12. Brain tumor related epilepsy: pathophysiological approaches and rational management of antiseizure medication.
Seidel S; Wehner T; Miller D; Wellmer J; Schlegel U; Grönheit W
Neurol Res Pract; 2022 Sep; 4(1):45. PubMed ID: 36059029
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study.
Bedetti C; Romoli M; Maschio M; Di Bonaventura C; Nardi Cesarini E; Eusebi P; Siliquini S; Dispenza S; Calabresi P; Costa C
Eur J Neurol; 2017 Oct; 24(10):1283-1289. PubMed ID: 28796376
[TBL] [Abstract][Full Text] [Related]
14. The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.
Connock M; Frew E; Evans BW; Bryan S; Cummins C; Fry-Smith A; Li Wan Po A; Sandercock J
Health Technol Assess; 2006 Mar; 10(7):iii, ix-118. PubMed ID: 16545206
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
[TBL] [Abstract][Full Text] [Related]
16. Perampanel in patients with brain tumor-related epilepsy in real-life clinical practice: a retrospective analysis.
Maschio M; Pauletto G; Zarabla A; Maialetti A; Ius T; Villani V; Fabi A; Koudriavtseva T; Giannarelli D
Int J Neurosci; 2019 Jun; 129(6):593-597. PubMed ID: 30507318
[TBL] [Abstract][Full Text] [Related]
17. VNS Therapy versus the latest antiepileptic drug.
Ben-Menachem E; French JA
Epileptic Disord; 2005 Sep; 7 Suppl 1():S22-6. PubMed ID: 16120490
[TBL] [Abstract][Full Text] [Related]
18. Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study.
Kerkhof M; Koekkoek JAF; Vos MJ; van den Bent MJ; Taal W; Postma TJ; Bromberg JEC; Kouwenhoven MCM; Dirven L; Reijneveld JC; Taphoorn MJB
J Neurooncol; 2019 May; 142(3):463-470. PubMed ID: 30778733
[TBL] [Abstract][Full Text] [Related]
19. Optimizing antiepileptic drug treatment in tumoral epilepsy.
Perucca E
Epilepsia; 2013 Dec; 54 Suppl 9():97-104. PubMed ID: 24328881
[TBL] [Abstract][Full Text] [Related]
20. Patients with brain tumor-related epilepsy.
Maschio M; Dinapoli L
J Neurooncol; 2012 Aug; 109(1):1-6. PubMed ID: 22528794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
